408 related articles for article (PubMed ID: 2108394)
1. Index of light kappa/lambda and lambda/kappa chains in monoclonal gammopathies.
Tichý M; Hrncír Z
Neoplasma; 1990; 37(1):55-9. PubMed ID: 2108394
[TBL] [Abstract][Full Text] [Related]
2. [Immunonephelometric analysis of immunoglobulin light chains: agreement between the theoretical and experimental model. Assessment of the reference values of the kappa/lambda ratio and the heavy to light chain ratio].
Chapuis-Cellier C; Cloppet H; Chazaud A; Coquelin H
J Pharm Belg; 1996; 51(1):23-27. PubMed ID: 8882446
[TBL] [Abstract][Full Text] [Related]
3. [A method for determining kappa-lambda quotients of immunoglobulins].
Jahn D; Domke K
Z Med Lab Diagn; 1987; 28(4):225-7. PubMed ID: 3114974
[No Abstract] [Full Text] [Related]
4. Kappa/lambda ratio on peripheral blood lymphocytes and bone marrow plasma cell labeling index in monoclonal gammopathies.
Büchi G; Girotto M; Veglio M; Clerico M; Gario S; Termine G; Autino R
Haematologica; 1990; 75(2):132-6. PubMed ID: 2113507
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
6. Coagulation disorders in patients with monoclonal gammopathies.
Keren DF
Hematol Oncol Clin North Am; 1993 Dec; 7(6):1153-9. PubMed ID: 8294313
[TBL] [Abstract][Full Text] [Related]
7. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies.
Cao F; Zhang R; Xu L; Liu M; Yuan Y
Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic significance of kappa/lambda and lambda/kappa ratio in paraproteinemias.
Tichý M; Hrncír Z
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(3-4):313-8. PubMed ID: 6820852
[No Abstract] [Full Text] [Related]
9. The frequency distribution of heavy chain classes and light chain types of 1,000 monoclonal immunoglobulins.
Creyssel R; Gibaud A; Cordier JF; Boissel JP
Biomedicine; 1975 Jan; 22(1):41-8. PubMed ID: 810190
[TBL] [Abstract][Full Text] [Related]
10. [Progression from Crow-Fukase syndrome with double gammopathy (IgM-kappa, IgG-lambda) to primary macroglobulinemia].
Fujii H; Yashige H; Kanoh T; Urata Y
Rinsho Ketsueki; 1991 Aug; 32(8):890-6. PubMed ID: 1942531
[TBL] [Abstract][Full Text] [Related]
11. Use of kappa and lambda chain quantitation for the detection of immunoglobulin abnormalities in serum.
Normansell DE
Diagn Clin Immunol; 1987; 5(2):100-3. PubMed ID: 3113758
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
[TBL] [Abstract][Full Text] [Related]
13. IgM-kappa-lambda biclonal gammopathy elucidated by immunofixation electrophoresis.
Gerard SK; Chen KH; Khayam-Bashi H
Diagn Immunol; 1986; 4(3):155-8. PubMed ID: 3089672
[TBL] [Abstract][Full Text] [Related]
14. Medical and technical usefulness of measurement of kappa and lambda immunoglobulin light chains in serum with an M-component.
Lievens MM
J Clin Chem Clin Biochem; 1989 Aug; 27(8):519-23. PubMed ID: 2509630
[TBL] [Abstract][Full Text] [Related]
15. [Serum IgA-lambda monoclonal gammopathy in a patient with immunoblastic sarcoma with IgM-kappa cell surface immunoglobulin].
Urbano Ispizua A; Estruch Riba R; Anegón I; Gallart T; Bladé J; Urbano-Márquez A; Rozman C
Med Clin (Barc); 1985 Mar; 84(10):405-7. PubMed ID: 3921785
[No Abstract] [Full Text] [Related]
16. [Laboratory diagnosis of monoclonal gammopathies. Prospective study of 14 cases in Dakar, Senegal].
Diop PA; Haudrechy D; Sylla-Niang M; Diedhiou A; Ngom L; Lopez-Sall P
Bull Soc Pathol Exot; 1998; 91(3):242-6. PubMed ID: 9773201
[TBL] [Abstract][Full Text] [Related]
17. [Immunochemical quantification of human monoclonal components].
Tagliaferri L; Losi G; Marannino V
Quad Sclavo Diagn; 1985 Sep; 21(3):306-16. PubMed ID: 3939038
[TBL] [Abstract][Full Text] [Related]
18. [Monoclonal gammopathies in a series of 1683 plasma donors].
Tichý M; Rehácek V; Maisnar V; Dominiková K; Palicka V
Cas Lek Cesk; 2004; 143(6):401-4; discussion 404. PubMed ID: 15309868
[TBL] [Abstract][Full Text] [Related]
19. [Experiences in the diagnosis and treatment of polyneuropathies in patients with malignant monoclonal gammopathy].
Baumann I; Krause T; Schwenke H; Lehmann J
Psychiatr Neurol Med Psychol (Leipz); 1990 Feb; 42(2):85-95. PubMed ID: 2158116
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
Wood PB; McElroy YG; Stone MJ
Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
